nogutsnoglory
Moderator
- Joined
- Sep 23, 2009
- Messages
- 8,908
The United States Food and Drug Administration (FDA) has approved its new 400 mg mesalamine product indicated for the treatment of ulcerative colitis. The Company released and marketed the product as DELZICOL™ (mesalamine) 400 mg delayed-release capsules.
Full article here: http://www.ccfa.org/news/delzicol.html
Full article here: http://www.ccfa.org/news/delzicol.html